Diode Laser Hair Removal: 808 nm Devices, Skin Types, and Sessions

An 808/810 nm diode laser is the most common hair-removal device, safe across Fitzpatrick I-VI with tuned settings, typically needing 6-8 sessions; Nd:YAG (1064 nm) is still the safest first choice for Fitzpatrick V-VI.

Diode lasers emit light in the near-infrared spectrum, typically centered around 800 to 810 nm (the LightSheer platform uses 805 nm and 1060 nm; Soprano Titanium blends 755/810/1064 nm), and target melanin in the hair shaft and bulge via selective photothermolysis. They have become the workhorse of modern laser hair removal because they combine high follicle absorption with usable safety across all Fitzpatrick skin types when fluence and pulse width are appropriately adjusted. Low-fluence, high-repetition "in-motion" diode protocols have specifically expanded treatment safety for darker skin. However, since only 15% to 20% of hairs are in the anagen (active growth) phase at any given time, a full course typically requires 6 to 8 sessions spaced 4 to 8 weeks apart, with maintenance over time. For Fitzpatrick V-VI, long-pulsed 1064 nm Nd:YAG remains the gold standard for safety; IPL is broader-spectrum, less follicle-selective, and generally limited to lighter skin.

---

How the 808/810 nm diode wavelength works, and which skin types is it safe for?

Wavelength physics and selective photothermolysis

The diode laser operates on the principle of selective photothermolysis. In this framework, a specific wavelength of light is delivered to target a chromophore (in this case, melanin in the hair follicle) while minimizing thermal damage to the surrounding dermal and epidermal structures. The target structures are the melanin-rich hair shaft, the follicular infundibulum, and the stem cells located in the bulge and bulb of the follicle.

To understand why the 808/810 nm wavelength is so effective, it must be examined in the context of the optical window of skin. The target chromophore is melanin, which is concentrated in the hair bulb and shaft. However, melanin is also present in the basal layer of the epidermis. Competitive chromophores include oxyhemoglobin (present in dermal capillaries) and water (present in all skin tissues).

• Melanin Absorption: Melanin absorption decreases as the wavelength increases. The 755 nm Alexandrite laser has very high melanin absorption, which provides excellent efficacy for light hair or fair-skinned patients but makes it highly dangerous for darker skin. The 808/810 nm diode wavelength represents a balanced middle ground: its melanin absorption coefficient is high enough to generate therapeutic heat in the hair follicle, yet low enough to minimize absorption in the basal layer of the epidermis.
• Depth of Penetration: Wavelength determines penetration depth. Longer wavelengths scatter less in the dermis, allowing for deeper penetration. The 808/810 nm wavelength penetrates approximately 2.0 to 3.0 mm into the skin. This allows it to reach the deep-seated terminal hair bulbs of the pubic region, underarms, and male back, which often sit in the deep reticular dermis.
• Hemoglobin and Water Window: At 808/810 nm, the absorption coefficients for both oxyhemoglobin and water are near their local minima in the near-infrared spectrum. This minimizes competitive absorption by dermal blood vessels and water-rich interstitial tissues, preventing bulk heating of the dermis and focusing the energy on the hair follicle.

When the diode laser fires, the light energy is absorbed by the melanin in the hair. This energy is rapidly converted into thermal energy, raising the temperature of the hair shaft and follicle to above 70°C. This thermal cascade coagulates the follicular cells and damages the surrounding dermal papilla, preventing the follicle from producing new hair.

Fitzpatrick skin type safety: from type I to VI

Historically, laser hair removal was restricted to patients with light skin and dark hair (Fitzpatrick types I to III). Darker skin types (Fitzpatrick IV to VI) carry higher concentrations of epidermal melanin. When treated with high-fluence, short-pulse lasers, the melanin in the skin competes with the melanin in the hair follicle. This leads to epidermal overheating, blistering, scarring, and post-inflammatory hyperpigmentation (PIH).

The 808/810 nm diode laser has bridged this gap. With appropriate pulse-width adjustments and epidermal cooling, it is safe for Fitzpatrick skin types I through V, and can be used on type VI under specialized protocols.

• Fitzpatrick I–III (Lighter Skin): Treatment is straightforward. High fluences (25 to 40 J/cm²) and relatively short pulse widths (10 to 30 ms) can be safely used because there is minimal epidermal melanin competition.
• Fitzpatrick IV–V (Olive/Brown Skin): Safety is maintained by lengthening the pulse width (up to 100 ms or more) and lowering the fluence. Extending the pulse duration beyond the thermal relaxation time of the epidermis (which is roughly 3 to 10 ms) allows the skin to dissipate heat while the larger hair follicle retains it.
• Fitzpatrick VI (Dark Brown/Black Skin): While the 1064 nm Nd:YAG laser remains the safest first-line choice for type VI skin due to its minimal melanin absorption, the diode laser can be used if it is operated in a low-fluence, high-repetition rate "in-motion" protocol.

The "In-Motion" (SHR) low-fluence protocol for dark skin

Traditional laser hair removal relies on "static" or "stamp" delivery, where a single, high-energy pulse is delivered to a stationary spot. While highly effective, this method creates rapid thermal spikes in the epidermis, making it risky for dark skin.

To address this, manufacturers introduced the Super Hair Removal (SHR) or "in-motion" method. Instead of firing one high-energy pulse, the handpiece is swept continuously across a defined treatment grid (e.g., 10 cm x 10 cm) while firing rapid, low-energy pulses (typically 10 Hz, or 10 pulses per second).

• Gradual Heating: The fluence per pulse is kept low (usually 8 to 10 J/cm²). The continuous movement gradually builds thermal energy within the dermis, heating the follicles to the target temperature while the active sapphire cooling tip keeps the epidermis cool.
• Clinical Evidence: A prospective 2025 clinical study published in Lasers in Medical Science evaluated the efficacy and safety of an 808 nm diode laser in Sudanese women with Fitzpatrick skin types IV to VI. The study utilized low-fluence (8–9 J/cm²), high-repetition rate protocols with integrated sapphire cooling. After only three sessions spaced three weeks apart, patients achieved a mean hair reduction of 57.9% in the underarms and 56.7% on the chin, with only transient erythema and no cases of blistering, scarring, or permanent pigmentary changes.

---

Which FDA-cleared diode devices exist, and what is their clearance lineage (LightSheer, Soprano, Vectus)?

The diode hair-removal market is highly regulated, and devices are classified by the FDA under the product code GEX (Powered Laser Surgical Instrument). To understand the market, one must look past the marketing names and examine the actual 510(k) clearances and corporate lineages of the primary platforms.

The LightSheer lineage (Lumenis)

The LightSheer family is widely considered the pioneer of diode laser hair removal. Its regulatory history reflects the consolidation of early laser companies:

1. The Original LightSheer (1998): The first LightSheer diode laser was cleared by the FDA under 510(k) K980420 on May 4, 1998. The applicant of record was Palomar Medical Products, Inc. — reflecting the patchwork of early laser-company ownership that the LightSheer family passed through before reaching Lumenis (formed in 2001 when ESC Medical Systems acquired Coherent Inc.'s Medical Group; the later LightSheer Duet, Desire, and Infinity clearances list Lumenis as applicant). It operated at 800 nm and introduced the patented ChillTip sapphire cooling window, which compressed the skin to displace capillary blood (reducing competitive hemoglobin absorption) while cooling the epidermis.
2. LightSheer Duet (2006): Cleared under 510(k) K053628 on April 7, 2006, by Lumenis, Inc. The Duet introduced a large-spot handpiece (22 x 35 mm) utilizing vacuum-assist technology. The vacuum gently pulls the skin into the handpiece cup, stretching the dermis thin and pulling the hair follicles closer to the laser source. This mechanical stretch dilutes epidermal melanin density and expels blood vessels from the target zone, allowing for effective hair removal at lower fluences (under 12 J/cm²) without the need for topical cooling gels.
3. LightSheer Desire (2015): Cleared under 510(k) K151947 on August 12, 2015, this system modularized the technology, offering interchangeable handpieces (both vacuum-assisted and ChillTip sapphire) to treat both large body areas and small, contoured facial areas.
4. LightSheer Desire Family Update (2017): Cleared under 510(k) K170179 on September 18, 2017, updating the console firmware and electrical safety standards across the Desire, Desire Light, Duet, and Infinity lines.

The Soprano family (Alma Lasers)

Alma Lasers developed the Soprano line, which became synonymous with the "in-motion" SHR technique.

1. The Original Soprano (2005): Cleared under 510(k) K052874 on November 22, 2005, under the applicant MSQ (M2), Ltd. (which later transitioned to Alma Lasers). It was one of the earliest diode systems to emphasize high-repetition-rate hair reduction.
2. Soprano XL and Soprano ICE (2009–2014): The Soprano XL platform was cleared under K083848 (April 14, 2009), followed by modifications under K102716 and K112031 (which introduced the specialized SHR handpiece modules). The Soprano ICE, cleared under K140009 on August 29, 2014, combined multi-wavelength diode modules (755 nm, 810 nm, and 1064 nm options) into a single console, allowing practitioners to change handpieces based on patient skin type.
3. Soprano Titanium (2022–2023): Cleared under K222064 (October 12, 2022) and updated under K230371 (February 22, 2023). The Soprano Titanium represents the modern state-of-the-art for the brand, utilizing a single handpiece that simultaneously emits three laser wavelengths: 755 nm (Alexandrite), 810 nm (Diode), and 1064 nm (Nd:YAG). This triple-wavelength approach targets different tissue depths and follicle structures simultaneously, while using an upgraded cooling system to maintain epidermal safety.

The Vectus laser (Palomar/Cynosure)

The Vectus laser was developed by Palomar Medical Technologies (which was subsequently acquired by Cynosure) and cleared under 510(k) K120622 on May 23, 2012.

• Technical Profile: Vectus is a high-power diode system operating at 810 nm. It features a large spot size (8.7 cm²) and uniform beam profile, designed for rapid treatment of large body areas.
• The Skintel Reader: A key feature of the Vectus clearance is the Skintel Melanin Reader. This is a handheld, FDA-cleared quantitative melanin measurement device. It measures the patient's skin pigmentation before treatment and transmits the data to the Vectus system, which automatically calculates the recommended starting fluence and pulse width. This removes provider guesswork and reduces the risk of burns on borderline Fitzpatrick skin types.

The Venus Velocity (Venus Concept)

Venus Concept entered the high-power diode segment with the Venus Velocity, cleared under 510(k) K162765 on January 11, 2017.

• Technical Profile: Velocity operates at 800 nm with a peak power of 2400 W and a maximum fluence of 40 J/cm².
• Modes of Operation: It features two distinct operating modes: PULSE mode (traditional static stamping with long pulse durations) and SLIDE mode (in-motion SHR style with high repetition rates of up to 10 Hz), allowing clinics to use a single device for both fast, low-pain treatments on large areas and targeted treatments on stubborn hair.

---

How many sessions does diode laser hair removal take, what does it cost, and what does the MAUDE safety data show?

Clinical session schedules and timelines

Hair follicles progress through three distinct developmental phases:

1. Anagen (Active Growth): The follicle contains abundant melanin and is actively connected to the dermal papilla. This is the only phase where the hair is vulnerable to permanent laser destruction.
2. Catagen (Regression): The hair follicle shrinks, the bulb detaches from the blood supply, and melanin production stops. Laser energy cannot destroy the stem cells during this phase.
3. Telogen (Resting): The hair is shed, and the follicle remains inactive. Melanin is absent from the root, making the laser ineffective.

Because only a small portion of hair is in the anagen phase at once, multiple sessions are required. The distribution varies by anatomical region:

Cost structure and variables

Diode laser hair removal is rarely priced as a single session; it is typically sold in packages of 6 or 8 treatments.

• Small Areas (Upper Lip, Chin, Sideburns): $75 to $150 per session ($450 to $900 for a package).
• Medium Areas (Underarms, Bikini Line, Forearms): $150 to $250 per session ($900 to $1,500 for a package).
• Large Areas (Full Legs, Back, Chest): $300 to $600 per session ($1,800 to $3,600 for a package).

Factors driving cost include geographic location, the medical credentials of the provider (dermatologist vs. technician), and the type of device used. High-power systems with advanced cooling or vacuum features command higher per-session prices due to increased equipment amortization costs, but they often require fewer total sessions than low-power, generic imports.

Post-market safety profile: openFDA MAUDE analysis

To evaluate the safety of diode hair-removal devices outside of controlled clinical trials, we analyzed the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. MAUDE aggregates mandatory and voluntary reports of adverse events, injuries, and device malfunctions.

A brand-name matching query was run against the public MAUDE dataset for major diode hair-removal platforms (including LightSheer, Soprano, Vectus, and Velocity). The query yielded 658 total adverse event reports. The breakdown of these events reveals important safety insights:

• Event Classification:
  • Injuries: 489 reports (74.3% of all cases).
  • Malfunctions: 73 reports (11.1%).
  • Other / Unclassified: 96 reports (14.6%).
• Distribution by Brand:
  • LightSheer Duet: 175 reports. (The high count reflects both its dominant market share and the unique vacuum handpiece, which can cause local petechiae or bruising if suction parameters are set too high).
  • LightSheer Desire: 58 reports.
  • LightSheer (All Models / General): 56 reports.
  • LightSheer ET: 53 reports.
  • Vectus: 32 reports.
  • Soprano Titanium: 11 reports. (The lower count may point to the protective effect of the in-motion low-fluence delivery system).

Analysis of injuries in MAUDE

The 489 injury reports are dominated by specific clinical complaints:

1. Second-Degree Burns and Blistering: The most common injury. This typically occurs when a practitioner treats tanned skin, uses excessive fluence, fails to use adequate cooling gel, or uses static stamping with a device set to high repetition rates.
2. Post-Inflammatory Hyperpigmentation (PIH) and Hypopigmentation: Often occurring weeks after a burn. Hypopigmentation (loss of skin color) happens when the laser destroys epidermal melanocytes. It can take 6 to 18 months to resolve, and may sometimes be permanent.
3. Paradoxical Hypertrichosis: A rare but documented reaction where laser treatment stimulates increased hair growth in adjacent areas. This is primarily seen on the face and neck of female patients of Mediterranean, Middle Eastern, or South Asian descent. It is believed to be caused by sub-therapeutic fluences that warm the follicle and stimulate dormant hair bulbs rather than destroying them.
4. Ocular Injury: A critical risk. Reports describe temporary or permanent pupillary damage, uveitis, and iris atrophy. These occur when treating the glabella (between the eyebrows) or eyebrows without proper ocular shields, or when the patient or provider removes their protective eyewear during the session.

---

Detailed Clinical Protocols and Parameters

To maximize hair clearance rates while avoiding the adverse events documented in the MAUDE database, clinics must establish rigorous, device-specific treatment parameters. The tables below outline representative starting settings based on patient Fitzpatrick skin type, hair characteristics, and the specific diode system used.

Static Stamping Diode Protocol (e.g., LightSheer Duet / Desire ChillTip)

The ChillTip sapphire handpiece relies on high peak power, moderate pulse durations, and aggressive contact cooling.

In-Motion SHR Diode Protocol (e.g., Soprano Titanium / Venus Velocity Slide)

The in-motion protocol uses high repetition rates, low fluences, and rapid passes to build heat in the dermis while keeping the epidermis safe.

Step-by-Step Clinical Workflow for Diode LHR

Adhering to a standardized workflow is the single most effective way to eliminate operator error.

Phase 1: Pre-Treatment Screening and Preparation

1. Melanin Reading: If utilizing a system with an integrated reader (e.g., Skintel on Vectus), take three separate readings on the treatment area. The system will calculate the average melanin index and lock in the maximum safe fluence.
2. Skin Cleaning: Thoroughly clean the skin to remove all topical anesthetics, cosmetics, deodorant, sunscreens, and body oils. These substances can act as competitive chromophores, leading to localized epidermal burns.
3. Shaving Verification: Ensure the area was clean-shaved 12 to 24 hours prior. Visible hair shafts above the skin line will absorb energy, vaporizing on the skin surface and causing immediate epidermal burns and singeing.
4. Grid Gridline Mapping: For large areas or in-motion protocols, use a white surgical skin marker to partition the area into 10 cm x 10 cm grids. Do not use red, blue, or black markers, as the laser will absorb those ink colors and burn the skin.

Phase 2: Laser Execution

1. Gel Application: If using a sapphire-cooling handpiece (static or in-motion), apply a 2–3 mm layer of clear, chilled laser transmission gel. The gel coupling minimizes refractive light loss at the air-stratum corneum interface and acts as a heat sink.
2. Contact Compression: Press the handpiece firmly against the skin. Contact compression is critical: it expels dermal blood vessels from the target path, minimizing competitive absorption by hemoglobin and bringing the hair bulbs closer to the window.
3. Overlap Pattern (Static Mode): Maintain a strict 10% to 15% spot overlap. Under-overlapping leaves untreated "stripes," while over-overlapping creates hot spots that can cause thermal injury.
4. Continuous Movement (In-Motion Mode): Keep the handpiece in constant motion. Never pause the handpiece while the foot pedal is depressed, as this will immediately dump high levels of thermal energy into one spot, causing a second-degree burn.

Phase 3: Post-Treatment Care

1. Gel Removal: Scrap off the laser gel and clean the skin with a cool, damp cloth.
2. Soothing Agent: Apply a thin layer of pure aloe vera gel or a low-potency topical steroid cream (such as 1% hydrocortisone) to soothe post-laser inflammation.
3. Sun Protection: Apply a broad-spectrum mineral sunscreen (SPF 30+ with zinc oxide or titanium dioxide) over all treated areas exposed to daylight.

---

Post-Treatment Complication Management

When adverse events occur, rapid and correct intervention determines whether a burn heals cleanly or turns into permanent scarring or pigment alteration.

Management of Epidermal Burns and Blisters

1. Immediate Cooling: If the patient reports intense burning during or immediately after the session, or if localized epidermal graying/whitening is observed, apply a cold compress or chilled ice pack wrapped in a clean towel for 10 to 15 minutes. Never apply ice directly to compromised skin, as this can cause frostbite injury.
2. Topical Antiseptics and Steroids: For first-degree burns (erythema without blistering), apply a mild topical steroid (1% hydrocortisone or 0.05% desonide cream) twice daily for 3 days to suppress the inflammatory cascade. For second-degree burns with intact blisters, apply a thin layer of topical antibiotic ointment (e.g., mupirocin or bacitracin) to prevent secondary infection. Do not debride or pop blisters, as the blister roof acts as a sterile biological dressing.
3. Occlusive Dressings: If blisters rupture, cover the area with a non-adherent silicone mesh dressing (e.g., Mepitel) and secure it with sterile gauze. Keep the wound bed moist to accelerate re-epithelialization.

Management of Post-Inflammatory Hyperpigmentation (PIH)

1. Photoprotection: Strictly avoid UV exposure. Apply SPF 50+ mineral sunscreen daily, regardless of weather, and wear sun-protective clothing. UV exposure stimulates melanocytes, worsening and prolonging PIH.
2. Topical Tyrosinase Inhibitors: Once the epidermal barrier has fully healed (typically 2 to 4 weeks post-burn), initiate topical therapy to suppress melanin synthesis. First-line agents include:
   • Hydroquinone (2% to 4%): Applied twice daily, cycled for a maximum of 3 to 4 months to prevent ochronosis.
   • Kojic Acid, Azelaic Acid (15% to 20%), or Tranexamic Acid: Used as alternatives or adjuncts for long-term maintenance.
3. Chemical Peels or Low-Fluence Q-Switched Lasers: For stubborn, deep dermal PIH, a series of gentle glycolic acid peels or low-fluence Q-switched Nd:YAG (1064 nm) treatments can be considered, but these must be performed with caution to avoid triggering secondary PIH.

---

Diode vs. Alexandrite vs. Nd:YAG vs. IPL

Choosing the right technology requires comparing the physical properties of the available systems; for full device-by-device detail, see our Alexandrite laser guide and Nd:YAG laser guide.

---

Contraindications and clinical precautions

To prevent the injuries documented in the MAUDE database, providers must screen for absolute and relative contraindications before initiating treatment:

Absolute contraindications

• Active Tanning or Sun Exposure: Patients must avoid direct sun exposure, tanning beds, and spray tans for at least 2 to 4 weeks before a session. Tanning increases melanin activity in the epidermis, raising the risk of severe burns.
• Active Skin Infection or Open Wounds: Treating over active herpes simplex, bacterial infections, or open wounds can cause systemic spread of infection or delay healing.
• Recent Use of Photosensitizing Medications: Oral isotretinoin (Accutane) must be discontinued for at least 6 months prior to treatment. Isotretinoin alters skin structure and increases the risk of epidermal tearing and atypical scarring.
• Personal History of Melanoma or Dysplastic Nevi: Laser energy should not be delivered over suspicious lesions or areas with active skin malignancies.
• Lack of Eye Protection: Treatments must not proceed without wavelength-specific protective goggles (OD > 5 at 800-810 nm) for all individuals in the room.

Relative contraindications and precautions

• Pregnancy and Breastfeeding: While there is no evidence of fetal harm from near-infrared light, treatments are typically deferred as a precaution and because hormonal fluctuations can cause melasma and temporary changes in hair growth patterns.
• History of Keloid or Atypical Scarring: High fluences must be avoided to minimize the risk of hypertrophic scar formation.
• History of Cold Sores (HSV): If treating the perioral area, patients should start prophylactic antiviral medication (e.g., valacyclovir) 24 hours before the session.
• Tattoos or Permanent Makeup: The laser must never be fired directly over a tattoo, as it will shatter the ink, causing severe burns, scarring, and permanent distortion of the artwork. Keep a safety margin of at least 2 cm.

---

Frequently Asked Questions

How many diode laser hair removal sessions do I need, and how far apart are they?

Most patients require 6 to 8 sessions to achieve optimal, long-lasting hair reduction. The exact number depends on the body area, hair color, and density. Hair grows in cycles, and the laser can only destroy follicles in the active growth (anagen) phase. Sessions are spaced:

• Face/Neck: Every 4 to 6 weeks.
• Trunk (Back, Chest, Abdomen): Every 8 to 10 weeks.
• Extremities (Arms, Legs): Every 8 to 10 weeks.

Adhering to the recommended intervals is critical; skipping sessions or extending intervals too long allows hair follicles to cycle out of the vulnerable anagen phase, reducing cumulative treatment efficacy.

Is a diode laser safe for dark skin (Fitzpatrick IV-VI)?

Yes, a diode laser is safe for darker skin types if the treatment parameters are adjusted correctly. While the 1064 nm Nd:YAG remains the safest first-line wavelength for Fitzpatrick V and VI, a diode laser can be used safely by:

1. Extending the pulse duration (up to 100 ms or more) to allow the epidermis to cool.
2. Using the "in-motion" (SHR) method, which uses rapid, low-energy pulses to gradually heat the follicles rather than a single, high-energy blast.
3. Utilizing aggressive cooling (such as a sapphire tip) to protect the skin surface.

Always verify that the provider has specific experience treating skin of color and performs a patch test before treating large areas.

---

Questions to ask your provider

Before beginning a course of diode laser hair removal, patients should ask the following questions to verify the credentials and safety protocols of the clinic:

1. "What is the exact brand name and wavelength of the device you will be using?"
   • Why: This helps identify whether the clinic is using an FDA-cleared device (such as a LightSheer, Soprano, or Vectus) or a cheap, non-cleared import with unstable energy output.
2. "What training and certifications does the operator hold?"
   • Why: State laws vary; in some states, unlicensed technicians can operate lasers under loose supervision. Ensure the operator is a licensed nurse, esthetician, or laser technician with specific training on the device.
3. "How will you adjust the treatment parameters for my specific Fitzpatrick skin type?"
   • Why: A qualified provider should explain how they adjust fluence, pulse duration, and cooling based on your skin tone, or discuss using the Skintel reader or performing a test spot.
4. "Do you have a medical director on-site or immediately available in case of an adverse event?"
   • Why: If a burn or blister occurs, the clinic must have a clear medical protocol and a prescribing clinician available to provide topical steroids or burn dressings.
5. "How do you sanitize the handpiece between patients?"
   • Why: The laser tip comes into direct contact with the skin and bodily fluids in sensitive areas. The clinic must follow strict infection control guidelines, using intermediate-level hospital disinfectants between every session.

---

Sources

• U.S. Food and Drug Administration. "510(k) Premarket Notification Database: LightSheer Diode Laser (K980420)." FDA, 1998. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cf510k/510k.cfm?id=K980420
• U.S. Food and Drug Administration. "510(k) Premarket Notification Database: LightSheer Duet (K053628)." FDA, 2006. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cf510k/510k.cfm?id=K053628
• U.S. Food and Drug Administration. "510(k) Premarket Notification Database: Soprano Titanium (K222064)." FDA, 2022. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cf510k/510k.cfm?id=K222064
• U.S. Food and Drug Administration. "510(k) Premarket Notification Database: Palomar Vectus (K120622)." FDA, 2012. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cf510k/510k.cfm?id=K120622
• U.S. Food and Drug Administration. "510(k) Premarket Notification Database: Venus Velocity (K162765)." FDA, 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cf510k/510k.cfm?id=K162765
• Lasers in Medical Science. "Efficacy and safety of 808 nm diode laser hair reduction in Sudanese women with Fitzpatrick skin types IV-VI." Springer Nature, 2025. https://link.springer.com/article/10.1007/s10103-025-04634-1
• PubMed Central. "Medical laser hair removal: a new rotational approach." National Library of Medicine, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC12364753
• American Academy of Dermatology. "Laser hair removal: Side effects." AAD, 2026. https://www.aad.org/public/diseases/a-z/laser-hair-removal-side-effects
• StatPearls. "Laser Hair Removal." NCBI Bookshelf, 2026. https://www.ncbi.nlm.nih.gov/books/NBK507861